Selvita reports Q1 2026 results and launches strategic options review

About this update from Silver Dollar Resources, Inc.

[{"type":"text","content":"Selvita reports Q1 2026 results and launches strategic options review\n\n\nSelvita reports Q1 2026 results and launches strategic options review\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPR Newswire\n\n\nKRAKÓW, Poland, May 21, 2026 /PRNewswire/ -- Selvita S.A. (WSE: SLV), one of the leading Drug Discovery and Development organizations in Europe, has published its financial results for Q1 2026 and latest backlog. The Company has decided to launch a strategic options review for the Group's further development and to maximize long-term shareholder value.\nThe Group's operating revenues in Q1 amounted to EUR 19.1 million, at the upper end of the preliminary estimated results range of EUR 18.4-19.3 million. The EBITDA margin(1) reached 14%, compared to the estimated range of 13-16%. As a result of the cost-saving program implemented in H2 2025, operating costs in Q1 2026 were reduced by approximately EUR 1.5 million.Drug Development segment: Commercial revenues increased by 6% y/y in Q1 2026 to EUR 6.2 million, representing 35% of the Group's commercial revenues. Segment EBITDA amounted to EUR 1.7 million, up 2% y/y(1). Segment backlog increased 15% y/y supporting the Group's expectation of continued future growth driven by strategic alignment to fast-growing modalities.Drug Discovery segment: Commercial revenues in Q1 2026 amounted to EUR 11.6 million, compared to EUR 15.6 million in the prior year. Segment EBITDA(1) amounted to EUR 1.0 million, compared to EUR 1.9 million in Q1 2025.  This was primarily due to the continuing challenging market for outsourced European drug discovery services companies and some project delays.The full-year 2026 backlog as of May 18, 2026 stands at EUR 58.1 million(2) compared to EUR 58.9 million last year.A webcast to discuss Selvita's Q1 results and outlook for 2026 will be held on May 21 at 11:00 CET. The event will be available at live.selvita.comSelvita announced the launch of a strategic review to assess options to support the Group's further development and maximize shareholder value.B...

More updates from Silver Dollar Resources, Inc.